|
시장보고서
상품코드
1973327
유아용 비강 CPAP 시장 규모, 점유율, 성장 분석 : 제품 유형별, 최종사용자별, 연령층별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)Infant Nasal CPAP Market Size, Share, and Growth Analysis, By Product Type (CPAP Devices, Accessories), By End User (Hospitals, Home Healthcare), By Age Group, By Distribution Channel, By Region - Industry Forecast 2026-2033 |
||||||
세계의 유아용 비강 CPAP 시장 규모는 2024년에 17억 달러로 평가되었고, 2025년 18억 2,000만 달러에서 2033년까지 31억 달러로 성장할 전망입니다. 또한, 예측 기간(2026-2033년) CAGR은 6.9%를 나타낼 것으로 예측됩니다.
세계 유아용 비강 CPAP 시장은 특히 폐가 미숙하고 지속적인 기도압이 필요한 미숙아를 포함한 신생아에게 비침습적인 호흡 지원을 제공하는 데 초점을 맞추었습니다. 시장 성장은 주로 조산아 증가와 저체중아 생존율 향상으로 인해 인공호흡기 관련 폐 손상을 최소화할 수 있는 안전한 호흡 치료의 필요성이 높아지면서 성장세를 견인하고 있습니다. 기술 발전은 기본적인 즉석 기술에서 버블 CPAP, 가열식 프롱 시스템 등 신생아 전용 고급 장치로 전환되고 있습니다. 의료 정책 및 직원 교육을 통한 효과적인 임상 도입은 시행의 일관성을 높입니다. AI는 적응형 제어와 실시간 조정을 가능하게 하고, 장비 성능을 혁신하여 궁극적으로 영아 관리와 운영 효율성을 향상시킵니다. 이러한 시너지 효과는 저자원 환경에서의 구독 서비스 및 원격 의료를 포함한 혁신적인 의료 모델의 기회를 촉진할 수 있습니다.
세계 유아용 비강 CPAP 시장 성장 촉진요인
신생아 생존율 향상에 대한 중요성이 높아짐에 따라, 특히 신생아 병동에서 비강 CPAP와 같은 비침습적 옵션을 포함한 첨단 호흡 보조 시스템에 대한 수요가 크게 증가하고 있습니다. 의료기관이 이러한 기술의 중요성을 인식함에 따라 조달 활동이 눈에 띄게 확대되고 있습니다. CPAP의 효과에 대한 임상의들의 신뢰가 높아짐에 따라 임상 현장에서 CPAP가 더 광범위하게 채택되고 기존 프로토콜에 통합되고 있습니다. 이에 따라 제조업체들은 의료진의 요구를 충족시키기 위해 특화된 제품 혁신과 개발을 진행하고 있습니다. 임상 실습과 장비 접근성 및 보조적 치료 인프라에 대한 투자 사이의 이러한 시너지 효과가 세계 영아 비강 캐뉼라 CPAP 시장의 괄목할 만한 성장을 견인하고 있습니다.
세계 유아용 비강 CPAP 시장 성장 억제요인
첨단 신생아 비강 CPAP 시스템과 관련된 높은 도입 및 유지보수 비용으로 인해 세계 영아 비강 CPAP 시장은 심각한 문제에 직면해 있습니다. 제한된 예산으로 운영되는 의료 서비스 제공업체는 비용 효율성을 정당화하기 어려운 경우가 많으며, 신제품보다 필수 장비를 우선시하거나 필요한 업그레이드를 미루는 경향이 있습니다. 재정적 제약은 의료 기관과 정책 결정 기관의 구매 결정에 큰 영향을 미치고, 노후화된 장비의 교체 속도를 늦추고 혁신적인 솔루션의 보급을 방해합니다. 그 결과, 시설에서 보다 효율적이고 현대적인 CPAP 기술에 투자하는 것보다 기존 장비의 사용 연장을 선택할 가능성이 있으며, 이러한 경제적 장벽이 시장 성장을 제한하고 있습니다.
세계 유아용 비강 CPAP 시장 동향
세계 유아용 비강 CPAP 시장에서는 제조업체와 의료 서비스 제공업체들이 신생아 중환자실(NICU) 이외의 환경에서도 사용할 수 있는 휴대가 간편하고 사용하기 쉬운 솔루션 개발에 박차를 가하면서 재택치료 환경으로 큰 전환이 일어나고 있습니다. 이러한 추세는 재택 간호로의 전환을 촉진하고 보호자와 의료진이 이러한 기기를 효과적으로 조작할 수 있도록 하는 것에 대한 중요성이 높아지고 있음을 보여줍니다. 안전 기능 강화, 설정 프로세스 간소화, 간병인 교육, 원격 모니터링 서비스와의 연계에 중점을 둠으로써 시장은 기존 의료 환경 밖에서 임상적 모니터링을 개선하는 동시에 병원의 가동률에 대한 부담을 줄이는 것을 목표로 하고 있습니다.
자주 묻는 질문
목차
서론
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 유아용 비강 CPAP 시장 규모 : 제품 유형별&CAGR(2026-2033)
세계의 유아용 비강 CPAP 시장 규모 : 최종사용자별&CAGR(2026-2033)
세계의 유아용 비강 CPAP 시장 규모 : 연령층별&CAGR(2026-2033)
세계의 유아용 비강 CPAP 시장 규모 : 유통 채널별&CAGR(2026-2033)
세계의 유아용 비강 CPAP 시장 규모&CAGR(2026-2033)
경쟁 정보
주요 기업 개요
결론과 제안
LSHGlobal Infant Nasal Cpap Market size was valued at USD 1.7 Billion in 2024 and is poised to grow from USD 1.82 Billion in 2025 to USD 3.1 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).
The global infant nasal CPAP market focuses on providing noninvasive respiratory support for neonates, particularly preterm infants with underdeveloped lungs requiring consistent airway pressure. The market's growth is largely driven by the increase in preterm births and higher survival rates of low birth weight infants, leading to a greater need for safe respiratory therapies that minimize ventilator-related lung injury. Advances have transitioned from basic, improvised technologies to sophisticated neonatal-specific devices, including bubble CPAP and heated-prong systems. Effective clinical adoption through health policies and staff training enhances implementation consistency. AI is transforming device performance by enabling adaptive control and real-time adjustments, ultimately improving infant care and operational efficiency. This synergy fosters opportunities for innovative healthcare models, including subscription services and telemedicine in lower-resource settings.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Infant Nasal Cpap market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Infant Nasal Cpap Market Segments Analysis
Global infant nasal cpap market is segmented by product type, end user, age group, distribution channel and region. Based on product type, the market is segmented into CPAP Devices and Accessories. Based on end user, the market is segmented into Hospitals and Home Healthcare. Based on age group, the market is segmented into Newborns and Infants. Based on distribution channel, the market is segmented into Online Sales and Retail Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Infant Nasal Cpap Market
The growing emphasis on enhancing neonatal survival rates has significantly boosted the demand for advanced respiratory support systems, particularly noninvasive options like nasal CPAP in neonatal units. As hospitals increasingly recognize the importance of these technologies, there is a notable expansion in procurement efforts. Clinicians' rising confidence in the effectiveness of CPAP leads to wider clinical adoption and integration into established protocols. In response, manufacturers are innovating and developing products tailored to meet the needs of healthcare providers. This synergistic relationship between clinical practices and investments in device accessibility and supportive care infrastructure drives significant growth in the Global Infant Nasal CPAP market.
Restraints in the Global Infant Nasal Cpap Market
The Global Infant Nasal CPAP market faces significant challenges due to the high acquisition and maintenance costs linked with advanced neonatal nasal CPAP systems. Healthcare providers operating with limited budgets may find it difficult to justify the expense, often prioritizing essential equipment over newer options or postponing necessary upgrades. Financial constraints heavily impact purchasing decisions across institutions and policy-making entities, leading to a slower pace in replacing outdated devices and hindering the widespread adoption of innovative solutions. Consequently, this economic barrier restricts market growth as facilities may opt to prolong the use of existing equipment rather than invest in more efficient, modern CPAP technologies.
Market Trends of the Global Infant Nasal Cpap Market
The Global Infant Nasal CPAP market is witnessing a significant shift toward homecare settings, as manufacturers and healthcare providers increasingly develop portable and user-friendly solutions designed for use beyond neonatal intensive care units. This trend highlights the growing emphasis on facilitating the transition to home care, making it easier for both parents and clinicians to operate these devices effectively. With a focus on safety features, simplified setup processes, caregiver education, and integration with remote monitoring services, the market aims to enhance clinical oversight outside traditional healthcare settings while alleviating pressure on hospital occupancy levels.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Infant Nasal CPAP Market Size by Product Type & CAGR (2026-2033)
- Market Overview
- CPAP Devices
- Standard CPAP Units
- Auto CPAP Units
- Accessories
- Nasal Masks
- Tubing
Global Infant Nasal CPAP Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Home Healthcare
Global Infant Nasal CPAP Market Size by Age Group & CAGR (2026-2033)
- Market Overview
- Newborns
- Infants
Global Infant Nasal CPAP Market Size by Distribution Channel & CAGR (2026-2033)
- Market Overview
- Online Sales
- Retail Pharmacies
Global Infant Nasal CPAP Market Size & CAGR (2026-2033)
- North America (Product Type, End User, Age Group, Distribution Channel)
- US
- Canada
- Europe (Product Type, End User, Age Group, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product Type, End User, Age Group, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product Type, End User, Age Group, Distribution Channel)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product Type, End User, Age Group, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- ResMed
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Philips Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fisher & Paykel Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vapotherm
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Breethe
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ABC Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Natus Medical Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NeoMed
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Drager
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Getinge Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Inova Robotics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Masimo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GE Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NIPRO Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ambu A/S
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vyaire Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hummingbird Pediatric
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Little Nurse
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bunnell Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
